166 related articles for article (PubMed ID: 8403611)
1. Use of gonadotropin-releasing hormone agonists before myomectomy.
Friedman AJ
Clin Obstet Gynecol; 1993 Sep; 36(3):650-9. PubMed ID: 8403611
[No Abstract] [Full Text] [Related]
2. Treatment of uterine leiomyomas in perimenopausal women with gonadotropin-releasing hormone agonists.
Nakamura Y; Yoshimura Y
Clin Obstet Gynecol; 1993 Sep; 36(3):660-7. PubMed ID: 8403612
[No Abstract] [Full Text] [Related]
3. Gonadotropin-releasing hormone agonists: utilization before hysterectomy.
Stovall TG
Clin Obstet Gynecol; 1993 Sep; 36(3):642-9. PubMed ID: 8403610
[No Abstract] [Full Text] [Related]
4. Pre-surgical treatment of uterine myomas with LH-RH agonists.
D'Addato F; Repinto A; Andreoli C
Clin Exp Obstet Gynecol; 1992; 19(1):45-50. PubMed ID: 1535032
[TBL] [Abstract][Full Text] [Related]
5. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
Andreyko JL; Blumenfeld Z; Marshall LA; Monroe SE; Hricak H; Jaffe RB
Am J Obstet Gynecol; 1988 Apr; 158(4):903-10. PubMed ID: 2966587
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up.
Letterie GS; Coddington CC; Winkel CA; Shawker TH; Loriaux DL; Collins RL
Fertil Steril; 1989 Jun; 51(6):951-6. PubMed ID: 2498132
[TBL] [Abstract][Full Text] [Related]
7. Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography.
Donnez J; Schrurs B; Gillerot S; Sandow J; Clerckx F
Fertil Steril; 1989 Jun; 51(6):947-50. PubMed ID: 2498131
[TBL] [Abstract][Full Text] [Related]
8. Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists.
Adamson GD
Am J Obstet Gynecol; 1992 Feb; 166(2):746-51. PubMed ID: 1531577
[TBL] [Abstract][Full Text] [Related]
9. Leuprolide depot before myomectomy.
Fribourg S
Fertil Steril; 1990 Apr; 53(4):754. PubMed ID: 2108064
[No Abstract] [Full Text] [Related]
10. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy.
Jasonni VM; D'Anna R; Mancuso A; Caruso C; Corrado F; Leonardi I
Acta Obstet Gynecol Scand; 2001 Oct; 80(10):956-8. PubMed ID: 11580742
[TBL] [Abstract][Full Text] [Related]
11. Uterine leiomyoma: treatment with LHRH agonist.
Maheux R; Lemay A
Prog Clin Biol Res; 1986; 225():297-311. PubMed ID: 3097669
[No Abstract] [Full Text] [Related]
12. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
[TBL] [Abstract][Full Text] [Related]
13. Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.
Gonzalez-Barcena D; Alvarez RB; Ochoa EP; Cornejo IC; Comaru-Schally AM; Schally AV; Engel J; Reissmann T; Riethmüller-Winzen H
Hum Reprod; 1997 Sep; 12(9):2028-35. PubMed ID: 9363724
[TBL] [Abstract][Full Text] [Related]
14. Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone.
Perl V; Marquez J; Schally AV; Comaru-Schally AM; Leal G; Zacharias S; Gomez-Lira C
Fertil Steril; 1987 Sep; 48(3):383-9. PubMed ID: 2957235
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis.
Friedman AJ; Lobel SM; Rein MS; Barbieri RL
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1114-9. PubMed ID: 2145765
[TBL] [Abstract][Full Text] [Related]
16. [Use of LH-RH agonists in uterine leiomyoma].
Maheux R
J Gynecol Obstet Biol Reprod (Paris); 1990; 19(5):603-6. PubMed ID: 2212519
[No Abstract] [Full Text] [Related]
17. [Preoperative management of uterine leiomyomatosis using pituitary gonadotropin-releasing hormone analogues].
Bustos López HH; Miranda Rodríguez JA; Kably Ambe A; Serviere Zaragoza C; Espinoza de los Monteros A; Alvarado Durán A
Ginecol Obstet Mex; 1995 Aug; 63():356-64. PubMed ID: 7672654
[TBL] [Abstract][Full Text] [Related]
18. The role of GnRH agonists in the treatment of uterine fibroids.
Healy DL; Vollenhoven BJ
Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():23-6. PubMed ID: 1554685
[No Abstract] [Full Text] [Related]
19. Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri.
Coddington CC; Collins RL; Shawker TH; Anderson R; Loriaux DL; Winkel CA
Fertil Steril; 1986 May; 45(5):624-9. PubMed ID: 3084300
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant therapy in uterine myoma].
Vikhliaeva EM
Vestn Ross Akad Med Nauk; 1997; (2):16-20. PubMed ID: 9376721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]